RunDe Peptide is a high-tech biotechnology enterprise that integrates peptide research and development, custom synthesis, large-scale production, and technical services. Specializing in the field of peptide chemistry, it provides a full-chain peptide solution for global pharmaceutical companies, biological research institutions, beauty and cosmetics ingredient manufacturers, and functional food organizations.
The company focuses on core products and customized services such as solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), specially modified peptides, long-chain peptides, cyclic peptides, GLP-1 innovative peptides, pharmaceutical peptide active pharmaceutical ingredients, beauty active peptides, and scientific research standard peptides. It has established a complete production capacity system from milligram-level laboratory samples, kilogram-level pilot scale-up to ton-level commercial mass production, and has opened up a full-process service chain for peptide CRO/CDMO.
Relying on mature peptide synthesis technology, precise analytical testing platforms, and standardized quality management systems, RunDe Peptide balances R&D flexibility and mass production stability, meeting stringent quality requirements in multiple scenarios such as drug development, clinical application, cosmetic formulations, and basic research in life sciences. Its products and services reach over 50 countries and regions worldwide.